The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI).
作者信息
Ghallab Ahmed
机构信息
Department of Forensic and Toxicology, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt.
出版信息
EXCLI J. 2014 Dec 15;13:1286-8. eCollection 2014.
Abstract
摘要
相似文献
1
The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI).用于预测药物性肝损伤（DILI）的HepG2细胞的重新发现。
EXCLI J. 2014 Dec 15;13:1286-8. eCollection 2014.
2
High content analysis assay for prediction of human hepatotoxicity in HepaRG and HepG2 cells.用于预测HepaRG和HepG2细胞中人肝毒性的高内涵分析检测法。
Toxicol In Vitro. 2016 Jun;33:63-70. doi: 10.1016/j.tiv.2016.02.019. Epub 2016 Feb 26.
3
Cell-based assay using glutathione-depleted HepaRG and HepG2 human liver cells for predicting drug-induced liver injury.基于谷胱甘肽耗竭的 HepaRG 和 HepG2 人肝癌细胞的细胞测定法用于预测药物性肝损伤。
Toxicol In Vitro. 2018 Apr;48:286-301. doi: 10.1016/j.tiv.2018.01.019. Epub 2018 Jan 31.
4
Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.基于证据选择用于人体药物性肝损伤机制整合预测的训练化合物。
Arch Toxicol. 2016 Dec;90(12):2979-3003. doi: 10.1007/s00204-016-1845-1. Epub 2016 Sep 22.
5
Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.用人肝微粒体培养的HepG2细胞中药物性肝损伤的预测
Chem Res Toxicol. 2015 May 18;28(5):872-85. doi: 10.1021/tx500504n. Epub 2015 Apr 17.
6
Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.基于机制的综合检测系统用于预测药物性肝损伤。
Toxicol Appl Pharmacol. 2020 May 1;394:114958. doi: 10.1016/j.taap.2020.114958. Epub 2020 Mar 18.
7
In-silico approach for drug induced liver injury prediction: Recent advances.计算机辅助药物性肝损伤预测方法：最新进展。
Toxicol Lett. 2018 Oct 1;295:288-295. doi: 10.1016/j.toxlet.2018.06.1216. Epub 2018 Jul 5.
8
Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.采用 HepG2-hNTCP-C4 细胞夹心式构建体外胆汁淤积性药物肝损伤评价系统的研究。
Toxicol In Vitro. 2019 Dec;61:104619. doi: 10.1016/j.tiv.2019.104619. Epub 2019 Aug 5.
9
The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.肝脏毒性知识库 (LKTB) 和药物性肝损伤 (DILI) 分类用于评估人类肝损伤。
Expert Rev Gastroenterol Hepatol. 2018 Jan;12(1):31-38. doi: 10.1080/17474124.2018.1383154. Epub 2017 Oct 9.
10
Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.使用加权分子指纹预测药物性肝毒性的模型
BMC Bioinformatics. 2017 May 31;18(Suppl 7):227. doi: 10.1186/s12859-017-1638-4.
引用本文的文献
1
Therapy of hyperammonemia.高氨血症的治疗
EXCLI J. 2015 Dec 22;14:1270-2. doi: 10.17179/excli2015-761. eCollection 2015.
2
Highlight report: New methods for quantification of bile canalicular dynamics.重点报告：胆管微管动力学定量分析的新方法
EXCLI J. 2015 Dec 21;14:1264-6. doi: 10.17179/excli2015-763. eCollection 2015.
3
Transcriptomic signature for drug-induced steatosis.药物性脂肪变性的转录组特征
EXCLI J. 2015 Dec 21;14:1259-60. doi: 10.17179/excli2015-758. eCollection 2015.
4
Highlight report: Blueprint for stem cell differentiation into liver cells.重点报告：干细胞分化为肝细胞的蓝图。
EXCLI J. 2015 Sep 2;14:1017-9. doi: 10.17179/excli2015-549. eCollection 2015.
5
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling.重点报告：基于生理药代动力学模型的种间外推
EXCLI J. 2015 Sep 1;14:1014-6. doi: 10.17179/excli2015-548. eCollection 2015.
本文引用的文献
1
Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytes.应用RNA干扰技术以增强对原代大鼠肝细胞中组学对肝毒性药物反应机制的理解。
Toxicology. 2014 Dec 4;326:86-95. doi: 10.1016/j.tox.2014.10.007. Epub 2014 Oct 22.
2
Free radical generation from an aniline derivative in HepG2 cells: a possible captodative effect.苯胺衍生物在 HepG2 细胞中生成自由基：一种可能的加捕获效应。
Free Radic Biol Med. 2015 Jan;78:111-7. doi: 10.1016/j.freeradbiomed.2014.10.577. Epub 2014 Nov 5.
3
Flutamide-induced cytotoxicity and oxidative stress in an in vitro rat hepatocyte system.氟他胺在体外大鼠肝细胞系统中诱导的细胞毒性和氧化应激。
Oxid Med Cell Longev. 2014;2014:398285. doi: 10.1155/2014/398285. Epub 2014 Oct 13.
4
Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.高良姜素通过激活转化生长因子-β受体/ Smad信号通路抑制肝癌细胞HepG2的增殖。
Toxicology. 2014 Dec 4;326:9-17. doi: 10.1016/j.tox.2014.09.010. Epub 2014 Sep 28.
5
A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies.一种具有改善的类肝特性的分化型HepG2细胞球体三维体外模型，用于重复剂量高通量毒性研究。
Arch Toxicol. 2014 May;88(5):1083-95. doi: 10.1007/s00204-014-1215-9. Epub 2014 Mar 6.
6
In Vitro Analysis of CsA-Induced Hepatotoxicity in HepG2 Cell Line: Oxidative Stress and α2 and β1 Integrin Subunits Expression.环孢素A诱导HepG2细胞系肝毒性的体外分析：氧化应激与α2和β1整合素亚基表达
Hepat Mon. 2013 Aug 13;13(8):e11447. doi: 10.5812/hepatmon.11447. eCollection 2013.
7
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.近年来，利用原代肝细胞、替代的肝细胞来源和非实质细胞的 2D 和 3D 体外系统在研究肝毒性、细胞信号转导和 ADME 的机制方面取得了进展。
Arch Toxicol. 2013 Aug;87(8):1315-530. doi: 10.1007/s00204-013-1078-5. Epub 2013 Aug 23.
8
Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells.五氯苯酚被全氟辛烷磺酸或全氟辛酸增强在 HepG2 细胞中的细胞毒性。
Chemosphere. 2013 Nov;93(9):2101-7. doi: 10.1016/j.chemosphere.2013.07.054. Epub 2013 Aug 22.
9
A special issue about hepatotoxicity and hepatocyte in vitro systems.关于肝毒性和体外肝细胞系统的特刊。
Arch Toxicol. 2013 Aug;87(8):1313-4. doi: 10.1007/s00204-013-1092-7.
10
An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis.深入了解安非他命单独及联合作用诱导的肝细胞死亡：坏死和凋亡的参与。
Arch Toxicol. 2013 Dec;87(12):2165-85. doi: 10.1007/s00204-013-1082-9. Epub 2013 Jul 3.
Zotero 插件